Technical Analysis for FREQ - Frequency Therapeutics, Inc.

Grade Last Price % Change Price Change
F 8.66 7.58% 0.61
FREQ closed up 7.58 percent on Friday, May 14, 2021, on 68 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical FREQ trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Reached Oversold Weakness 7.58%
Multiple of Ten Bearish Other 7.58%
Below Lower BB Weakness 7.58%
Lower Bollinger Band Touch Weakness 7.58%
Oversold Stochastic Weakness 7.58%
Fell Below 20 DMA Bearish -14.26%
Inside Day Range Contraction -14.26%
Older End-of-Day Signals for FREQ ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 10% 3 days ago
Up 5% 3 days ago
60 Minute Opening Range Breakout 3 days ago
Rose Above Lower Bollinger Band 3 days ago
Up 3% 3 days ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Frequency Therapeutics is a clinical-stage biotechnology company focused on harnessing the body’s innate biology to repair or reverse damage caused by a broad range of degenerative diseases. Frequency’s progenitor cell activation (PCA) approach stimulates progenitor cells to create functional tissue with the aim of developing disease modifying therapeutics. The company’s lead product candidate, FX-322, is in clinical development and is designed to regenerate auditory hair cells to restore hearing function in patients with sensorineural hearing loss, the most common form of hearing loss. The company is also evaluating its PCA approach in additional diseases, including multiple sclerosis.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biology Clinical Development Disease Hearing Occupational Safety And Health Multiple Sclerosis Degenerative Disease Degenerative Diseases Perception Audiology Hearing Loss Progenitor Cell Deafness Auditory System Sensorineural Hearing Loss Hair Cell

Is FREQ a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 58.33
52 Week Low 7.3351
Average Volume 1,823,137
200-Day Moving Average 26.53
50-Day Moving Average 16.62
20-Day Moving Average 10.20
10-Day Moving Average 10.03
Average True Range 1.28
ADX 34.13
+DI 12.74
-DI 34.59
Chandelier Exit (Long, 3 ATRs ) 8.35
Chandelier Exit (Short, 3 ATRs ) 11.58
Upper Bollinger Band 11.82
Lower Bollinger Band 8.58
Percent B (%b) 0.02
BandWidth 31.74
MACD Line -1.82
MACD Signal Line -2.24
MACD Histogram 0.4155
Fundamentals Value
Market Cap 292.14 Million
Num Shares 33.7 Million
EPS -0.64
Price-to-Earnings (P/E) Ratio -13.63
Price-to-Sales 29.89
Price-to-Book 4.75
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.62
Resistance 3 (R3) 10.53 9.79 10.29
Resistance 2 (R2) 9.79 9.29 9.83 10.18
Resistance 1 (R1) 9.23 8.98 9.51 9.31 10.07
Pivot Point 8.49 8.49 8.63 8.53 8.49
Support 1 (S1) 7.92 7.99 8.20 8.01 7.25
Support 2 (S2) 7.18 7.68 7.22 7.14
Support 3 (S3) 6.62 7.18 7.03
Support 4 (S4) 6.70